Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations

Award Number: R13CA310704
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/03/2026
PERIOD OF PERFORMANCE END DATE: 02/28/2027

Group Awards By:

View Award Description

Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations - Abstract Support is requested for a Keystone Symposia conference entitled “Cancer Immunotherapy: Basic Mechanism Informing Clinical Applications & Combinations” organized by Drs. Jennifer Guerriero, Thomas Marron, Ira Mellman and Solange Peters, with scientific programming input from Keystone Symposia. The meeting will take place at the Fairmont Le Château Frontenac in Quebec City, Quebec, Canada from March 15–19, 2026. While cancer immunotherapy strategies are highly effective, they target only a few immunoregulatory pathways and benefit a limited subset of patients. Most patients either fail to respond or respond briefly before developing resistance. This Keystone Symposia meeting aims to better understand the mechanisms behind this resistance and discuss the immunotherapeutic strategies under development that will harness alternative immune pathways to improve clinical responses. Conference sessions will highlight emerging approaches to targeting stromal and myeloid cells, insights into tumor recognition by lymphoid lineages, and the use of advanced technologies like spatial imaging and AI to understand the tumor microenvironment. Specifically, this meeting will convene leading cancer immunotherapy experts to review the successes and failures of existing therapies, explore new therapeutic targets within host immunity, and discuss the challenges and potential of combination therapies. These interdisciplinary perspectives will provide insight into future clinical applications of novel approaches and optimal combination therapies to advance strategies designed to eliminate cancers through innovative therapeutic approaches using the immune response.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $5,000 )
2026	2026	KEYSTONE SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY	160 HWY 6 STE 201	SILVERTHORNE	CO	80498	SUMMIT	USA	Cancer Detection and Diagnosis Research	000	1	3/3/2026	NEW	$5,000
														Subtotal = $5,000

Grand Total All Awards = $5,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations

Award Number: R13CA310704

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/03/2026

PERIOD OF PERFORMANCE END DATE: 02/28/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer